These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8487917)

  • 1. Continuous ICV infusion of scopolamine impairs sustained attention of rhesus monkeys.
    Callahan MJ; Kinsora JJ; Harbaugh RE; Reeder TM; Davis RE
    Neurobiol Aging; 1993; 14(2):147-51. PubMed ID: 8487917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scopolamine impairs auditory delayed matching-to-sample performance in monkeys.
    Plakke B; Ng CW; Poremba A
    Neurosci Lett; 2008 Jun; 438(1):126-30. PubMed ID: 18455309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence against a specific effect of cholinergic drugs on spatial memory in primates.
    Rupniak NM; Samson NA; Tye SJ; Field MJ; Iversen SD
    Behav Brain Res; 1991 Apr; 43(1):1-6. PubMed ID: 1859616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scopolamine impairs recall of one-trial stimulus-reward association in monkeys.
    Aigner TG; Mishkin M
    Behav Brain Res; 1993 Apr; 54(2):133-6. PubMed ID: 8323711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining tacrine with milameline reverses a scopolamine-induced impairment of continuous performance in rhesus monkeys.
    Callahan MJ
    Psychopharmacology (Berl); 1999 Jun; 144(3):234-8. PubMed ID: 10435389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills.
    Duka T; Ott H; Rohloff A; Voet B
    Psychopharmacology (Berl); 1996 Feb; 123(4):361-73. PubMed ID: 8867876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scopolamine slows the orienting of attention in primates to cued visual targets.
    Davidson MC; Cutrell EB; Marrocco RT
    Psychopharmacology (Berl); 1999 Feb; 142(1):1-8. PubMed ID: 10102776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scopolamine alters rhesus monkey performance on a novel neuropsychological test battery.
    Taffe MA; Weed MR; Gold LH
    Brain Res Cogn Brain Res; 1999 Oct; 8(3):203-12. PubMed ID: 10556599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vinconate on scopolamine-induced memory impairment in rhesus monkeys.
    Ando K; Hironaka N; Shuto K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):43-6. PubMed ID: 12690640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys.
    Terry AV; Buccafusco JJ; Jackson WJ
    Pharmacol Biochem Behav; 1993 Aug; 45(4):925-9. PubMed ID: 8415832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates.
    Buccafusco JJ; Terry AV; Webster SJ; Martin D; Hohnadel EJ; Bouchard KA; Warner SE
    Psychopharmacology (Berl); 2008 Aug; 199(3):481-94. PubMed ID: 17657478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scopolamine-induced deficits in spontaneous alternation performance: attenuation with lateral ventricle injections of glucose.
    Parsons MW; Gold PE
    Behav Neural Biol; 1992 Jan; 57(1):90-2. PubMed ID: 1567337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scopolamine challenges in Alzheimer's disease.
    Sunderland T; Tariot P; Murphy DL; Weingartner H; Mueller EA; Cohen RM
    Psychopharmacology (Berl); 1985; 87(2):247-9. PubMed ID: 3931154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus Monkeys.
    Lange HS; Cannon CE; Drott JT; Kuduk SD; Uslaner JM
    J Pharmacol Exp Ther; 2015 Dec; 355(3):442-50. PubMed ID: 26446308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MK-801 impairs recognition memory in rhesus monkeys: comparison with cholinergic drugs.
    Ogura H; Aigner TG
    J Pharmacol Exp Ther; 1993 Jul; 266(1):60-4. PubMed ID: 8331575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scopolamine induced deficits in a battery of rat cognitive tests: comparisons of sensitivity and specificity.
    Hodges DB; Lindner MD; Hogan JB; Jones KM; Markus EJ
    Behav Pharmacol; 2009 May; 20(3):237-51. PubMed ID: 19436198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent stimulation in the nucleus basalis of meynert improves sustained attention in rhesus monkeys.
    Liu R; Crawford J; Callahan PM; Terry AV; Constantinidis C; Blake DT
    Neuropharmacology; 2018 Jul; 137():202-210. PubMed ID: 29704983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of a glycine reuptake inhibitor R231857 on the central nervous system and on scopolamine-induced impairments in cognitive and psychomotor function in healthy subjects.
    Liem-Moolenaar M; Zoethout RW; de Boer P; Schmidt M; de Kam ML; Cohen AF; Franson KL; van Gerven JM
    J Psychopharmacol; 2010 Nov; 24(11):1681-7. PubMed ID: 19648218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurosteroid pregnenolone sulfate reduces learning deficits induced by scopolamine and has promnestic effects in mice performing an appetitive learning task.
    Meziane H; Mathis C; Paul SM; Ungerer A
    Psychopharmacology (Berl); 1996 Aug; 126(4):323-30. PubMed ID: 8878348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cognitive impairment by scopolamine and noncholinergic agents in rhesus monkeys.
    Rupniak NM; Samson NA; Steventon MJ; Iversen SD
    Life Sci; 1991; 48(9):893-9. PubMed ID: 1847737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.